Enrolling by Invitation
Phase 3
Age: 18Years +
All Genders
ID06150560
A Phase III, Randomized, Double-Blind, Placebo Controlled Clinical Trial Evaluating the Benefits and Mechanism Of Action Of Angiotensin-II Receptor Blocker On Cardiovascular Remodeling In Patients With Repaired Coarctation Of Aorta
Led by Mayo Clinic · Updated on 2026-08-11
120
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the effectiveness and mechanism of action of Losartan in the treatment of coarctation of aorta.
CONDITIONS
Brief Title
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here